Effects of Propranolol on the Left Ventricular Volume of Normal Subjects During CT Coronary Angiography by Mo, Yuan Heng et al.
Korean J Radiol 12(3), May/Jun 2011 kjronline.org 319
Effects of Propranolol on the Left Ventricular Volume of 
Normal Subjects During CT Coronary Angiography
Yuan Heng Mo, MD
1-3, Fu Shan Jaw, MD
1, Yung Cheng Wang, MD
2, 3, Chin Ming Jeng, MD
2, 3,  
Shinn Forng Peng, MD
4
1Institute of Biomedical Engineering, College of Engineering and the College of Medicine, National Taiwan University, Taipei, Taiwan; 
2Department 
of Radiology, Cathay General Hospital, Taipei, Taiwan; 
3College of Medicine, Fu Jen Catholic University, Taipei, Taiwan; 
4Department of Medical 
Imaging, National Taiwan University Hospital, Taipei, Taiwan 
Objective: The purpose of this study is to determine the effects of propranolol on the left ventricular (LV) volume during 
CT coronary angiography.
Materials and Methods: The LV volume of 252 normal Chinese subjects (126 subjects with propranolol medication and 126 
age- and gender-matched Chinese subjects without medication) was estimated using 64 slices multi-detector CT (MDCT). 
The heart rate difference was analyzed by the logistic linear regression model with variables that included gender, age, 
body height, body weight, systolic blood pressure (SBP), diastolic blood pressure (DBP) and the dosage of propranolol. 
The following global LV functional parameters were calculated: the real-end diastolic volume (EDV), the real-end systolic 
volume (ESV) and the real-ejection fraction (EF). 
Results: The female subjects had a greater decrease of heart rate after taking propranolol. The difference of heart rate 
was negatively correlated with the dosage of propranolol. The real-EDV, the real-ESV and the real-EF ranged from 48.1 
to 109 mL/m
2, 6.1 to 57.1 mL/m
2 and 41% to 88%, respectively. There was no significant difference in the SBP and 
DBP between the groups without and with propranolol medication (123 ± 17 and 80 ± 10 mmHg; 120 ± 14 and 80 ± 11 
mmHg, respectively). The real-EDV showed no significant difference between these two groups, but the real-ESV and real-
EF showed significant differences between these two groups (69.4 ± 9.3 and 70.6 ± 8.9 mL/m
2; 23.5 ± 5.7 and 25.6 ± 3.7 
mL/m
2, 66.5 ± 5.1% and 63.5 ± 4.6%, respectively).
Conclusion: The difference of heart rate is significantly influenced by gender and the dosage of propranolol. Propranolol 
will also increase the ESV, which contributes to a decreased EF, while the SBP, DBP and EDV are not statistically changed.
Index terms:   Left ventricular volume; Ejection fraction; Heart rate; Beta-blocker; Propranolol, 64-slice MDCT; CT coronary 
angiography
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INTRODUCTION
CT coronary angiography using 64-slice multi-detector 
CT (MDCT) is an emerging, less invasive imaging 
modality for evaluating the coronary arteries (1-5). CT 
coronary angiography is obtained by using retrospective 
electrocardiography (ECG)-gating and this allows the 
reconstruction of datasets in any phase of the cardiac cycle. 
In addition to the angiography, the dimensions and volumes 
of the cardiac chambers can be measured at the same time 
while performing the CT coronary angiography examination 
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slice MDCT scanner (Brilliance; Philips Medical Systems, 
Cleveland, OH) during a single breath-hold period (8-10 
seconds). The parameters of our scanning protocol were 
64 × 0.625-mm collimation, 120-140 kV, 800-1000 mA, 
a 0.42 second rotation time, a pitch value of 0.2, a 0.8-
mm slice thickness and a 0.6-mm reconstruction interval. 
The bolus-tracking method was used and the scanning field 
included the entire heart from the proximal aorta (1-2 cm 
below the carina) to the cardiac apex. Sixty to 90 mL of 
iodinated contrast medium (Ioversol, Optiray 320 mg I/
mL, Tyco Healthcare, Canada) was injected intravenously via 
an antecubital vein at a flow rate of 5 mL/s and this was 
followed by 50 mL of saline at the same flow rate. A region 
of interest was placed on the aortic root. The scan was 
automatically initiated 6 seconds after the CT number of the 
region of interest reached 120 Hounsfield units. According 
to the scanning protocol of our hospital, no radiation dose 
modulation was used to secure good image quality. The 
average radiation dose was 17.9 ± 3.2 mSv.
Image Analysis 
The retrospective ECG-gated reconstructions were 
performed to generate image data at every 5% of the R-R 
interval from 0% to 95% of the R-R interval and then the 
image data was transferred to the workstation for further 
post-processing (Philips Extended Brilliance Workspace 
v3.5, The Netherland). The LV volume of twenty phases 
was estimated by semi-automated methods and this was 
normalized by the body surface area. The endocardial 
contours were automatically detected by the software of 
the workstation; the contour detection was visually checked 
and manually corrected if considered necessary (Fig. 1A, 
B). Papillary muscles were included in the LV cavity. The 
following global LV functional parameters were calculated: 
the minimal volume as the end-systolic volume (real-ESV), 
the maximal volume as the end-diastolic volume (real-EDV) 
and the ejection fraction (real-EF) by using the formula EF 
(%) = (EDV-ESV) × 100 / EDV. 
Data Collection and Statistical Analysis
The average heart rates before the CT scans, after 
medication if necessary, after breath holding and during 
the CT scans were recorded. The dosage of propranolol, 
the heart rate, the systolic blood pressure (SBP) and the 
diastolic blood pressure (DBP) before and after taking 
propranolol were recorded. 
Data analysis was performed using the STATA 10 software 
For patients with cardiac diseases such as coronary artery 
disease or cardiomyopathy, precise and reliable assessment 
of the left ventricular (LV) function and dimensions are 
important for predicting the prognosis (7). Previous studies 
have demonstrated that the retrospectively, ECG-gated MDCT 
determination of the LV volumes and consequently the 
global LV function parameters was feasible and the results 
were in good agreement with the established imaging 
modalities such as cine ventriculography, echocardiography 
and cine magnetic resonance imaging (6-26).
A regular and appropriate range of the heart rate (below 
65 beats per minute in our hospital) is necessary for good 
imaging quality. A beta-blocker such as propranolol is the 
most widely used drug to slow down the heart rate. Previous 
studies reported that propranolol had inhibitory effects on 
the LV function (27-30). However, the sample size of those 
studies was small and there has been only one study that 
reported about the hemodynamic effects of propranolol in 
normal subjects. The purpose of this retrospective study is 
to determine the effects of propranolol (10 mg) on the LV 
volume during CT coronary angiography in normal subjects.
MATERIALS AND METHODS
Study Population
According to our cardiac imaging data base, 897 
Chinese subjects came to our hospital for health screening 
examinations, which included CT coronary angiography, from 
March 2007 to July 2008. All the subjects received beta-
blocker (propranolol, 10 mg) per-oral 30 minutes before 
the CT scan, except those having a heart rate below 65 
beats per minutes. The dosage of propranolol was adjusted 
according to the heart rate to ensure the heart rate was 
below 65. A total of 403 subjects were excluded from this 
study due to one of the following criteria: 1) any luminal 
diameter stenosis in any of the coronary arteries found on 
images, 2) arrhythmia or an abnormal ECG, or 3) a history of 
hypertension with or without medication. In the remaining 
494 subjects, 126 who took propranolol to decrease their 
heart rate and another 126 age- and gender-matched ones 
who had a heart rate below 65 beats were chosen for this 
retrospective study. The approval from the institutional 
ethical committee was obtained before undertaking the 
study. Informed consent was not required.
CT Coronary Angiography Protocol
CT coronary angiography was performed on a 64-Korean J Radiol 12(3), May/Jun 2011 kjronline.org 321
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A
Fig. 1. Left ventricular volume of twenty 
phases’ estimation. 
A. Cardiac axial images were automatically 
calculated and displayed on workstation. 
If necessary, we corrected axis by rotating 
vertical long axis (black solid line) to make 
axis orthogonal to plane of mitral valve and 
it passed center of mitral valve and apex. 
We defined area of interest by designating 
cardiac apex and concave center of mitral 
valve on planar images (dash horizontal short 
lines). B. Nine-slices of short-axis sections 
and contours of endocardial border of left 
ventricle were automatically traced and 
when necessary, traced contours were edited 
manually. Volume of papillary muscles was 
included in volume of ventricle.
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(Stata, TX). To evaluate the inter- and intra-observer 
reproducibility, two observers performed the analyses 
independently and one did the second analyses the next 
week. We then calculated the concordance correlation 
coefficient for the continuous data. We tested whether the 
volume of a particularly chosen diastolic phase such as the 
0% phase and the systolic phase such as the 35%, 40% 
and 45% phases could replace the real-EDV and the real-
ESV through the use of Student’s t-test. The heart rate 
difference was analyzed by the logistic linear regression 
model for the mixture of categorical and numerical data 
with the independent variables, which included the 
gender, age, height, weight, SBP, DBP and the dosage of 
propranolol. The differences of parameters, including the 
real-EF, real-EDV, real-ESV, SBP and DBP, in 252 subjects 
whether or not propranolol medication was used were 
tested through Student’s t-test. P values less than 0.05 
were considered statistically significant.
RESULTS
A total of 252 normal subjects (M:F = 150:102; mean 
age, 56 ± 11 years; mean body height, 163.1 ± 8.3 cm; 
mean body weight, 66.7 ± 12 kg and mean body surface 
area, 1.72 ± 0.18 m
2) (Table 1) were included in this study. 
All the images of the coronary CT angiography were of 
diagnostic image quality. For the inter-observer analysis, 
no statistically significant difference was found between 
the estimations of the real-EDV (r = 0.976, p > 0.05) and 
the real-ESV (r = 0.957, p > 0.05). For the intra-observer 
analysis, no statistically significant difference was found 
between the repeated measurements of the real-EDV (r = 
0.996, p > 0.05) and the real-ESV (r = 0.997, p > 0.05).
The mean heart rate of the 126 subjects who did not take 
propranolol was 59 ± 6 beats per minute; the mean heart 
rates of the other 126 subjects, who had taken propranolol, 
was 72 ± 7 beats per minute before medication and 63 ± 
5 beats per minute after medication, respectively. After 
evaluation of the factors, including gender, age, height, 
weight, SBP, DBP and the number of pills of 10 mg  
propranolol from the logistic regression model, the difference 
of heart rate before and during CT scan was significantly 
influenced only by gender and dosage of beta-blocker (Table 
2). 
The LV volume of the total 252 subjects was estimated 
and normalized; the real-EDV ranged from 48.1 to 109 
(mean: 70.9 ± 9.9) mL/m
2 and the real-ESV ranged from 
6.1 to 57.1 (mean: 24.6 ± 6.9) mL/m
2. The real-EF ranged 
from 41% to 88% (mean: 65.6 ± 7%). According the volume 
data of twenty phases, a volume-time curve (Fig. 2) was 
obtained. The three global LV functional parameters showed 
no difference according to gender. The mean real-EDV, the 
real-ESV and the real-EF of the male and female subjects 
were 69.1 ± 9.3 and 70.8 ± 8.9 mL/m
2 (p > 0.05), 24.1 ± 5.6 
and 24.7 ± 4.3 mL/m
2 (p > 0.05) and 65.3 ± 5.5 and 65.1 
± 4.8% (p > 0.05), respectively. Fifty eight percent (147 of 
252) of the subjects had a maximal LV volume at the 0% 
phase and 42% (105 of 252) had a maximal LV volume at 
the 95% phase. Two percent (4 of 252) of the subjects had 
a minimal volume at the 30% phase, 32% (81 of 252) had 
a minimal LV volume at the 35% phase, 52% (131 of 252) 
Table 1. Demographic Data of 126 Normal Subjects with Propranolol Medication and 126 Normal Subjects without 
Medication
With Propranolol Without Medication P Value
Gender (Male:Female) 75:51 75:51
Age (years) 56 ± 10 55 ± 11 0.0566
Body height (cm) 162.2 ± 8 163.8 ± 8.5 0.0681
Body weight (kg) 66.4 ± 12.2 67.1 ± 12 0.6136
Body surface area (m
2) 1.71 ± 0.18 1.73 ± 0.18 0.1689
Table 2. Analysis of Heart Rate Difference Using 
Logistic Linear Regression Model after Deletion of 
Noncontributory Factors
Heart Rate Difference
Coefficient  P Value
Gender -1.27 0.011*
Number of pills of 
propranolol (10 mg) 
3.29 0*
Constant  -2.42 0*
Note.— Pseudo R-squared = 0.79
*for significant valueKorean J Radiol 12(3), May/Jun 2011 kjronline.org 323
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had a minimal LV volume at the 40% phase, 14% (35 of 
252) had a minimal LV volume at the 45% phase and 0.4% (1 
of 294) had a minimal LV volume at the 50% phase. 
The mean difference between the real-EDV (70.9 ± 9.9 
mL/m
2), the 0% EDV (70.5 ± 9.8 mL/m
2), and the mean 
difference between the real-EDV, the 95% phase EDV (70.1 
± 10 mL/m
2) had no statistical significance (p > 0.05), and 
neither did the mean difference between the real-ESV (24.6 
± 6.9 mL/m
2) and the 40% phase LV volume (26.4 ± 7.5 
mL/m
2, p > 0.05). However, the mean difference between 
the real-ESV, the 35% phase LV volume (26.4 ± 7.5 mL/m
2, 
p = 0.0023), and the mean difference between the real-
ESV, the 45% phase LV volume (28.9 ± 8.1 mL/m
2, p = 0) 
were significantly different as were the real-EF (65.6 ± 7%) 
compared to the EF calculated from the 0-35% (62.8 ± 7.9%, 
p = 0), 0-40% (64.1 ± 7.3%, p = 0.01) and 0-45% phase 
volumes (59.3 ± 8.6%, p = 0). The percentage of the mean 
difference between the real- and 0-35%, the real- and 
0-40% and the real- and 0-45% phase EF was 3%, 2% and 
6%, respectively. 
The mean SBP and DBP of the 126 subjects who had 
not taken propranolol was 123 ± 17 and 80 ± 10 mmHg, 
respectively. The mean SBP and DBP of the other 126 
subjects, who had taken propranolol, were 120 ± 14 mmHg 
and 80 ± 11 mmHg, respectively. There was no significant 
difference in the SBP and DBP between these two groups 
(p > 0.05). The real-EDV, real-ESV and real-EF were 69.4 ± 
9.3 mL/m
2, 23.5 ± 5.7 mL/m
2 and 66.5 ± 5.1% for the 126 
subjects without the medication, respectively; and the real-
EDV, real-ESV and real-EF were 70.6 ± 8.9 mL/m
2, 25.6 ± 
3.7 mL/m
2 and 63.5 ± 4.6% for the 126 subjects who had 
taken propranolol, respectively. The real-ESV and real-EF 
had significant differences between the groups without and 
with medication (p < 0.05), but the real-EDV showed no 
significant difference between these two groups (Table 3).
DISCUSSION
Beta-blocker is commonly used to reduce the heart rate to 
less than 65 beats per minutes in order to get good imaging 
quality for coronary angiography. Our results show the heart 
rate difference is influenced by gender and the administered 
dosage of propranolol during CT coronary angiography. The 
female subjects in our study had a greater decrease of the 
heart rate than did the males after taking propranolol. One 
report showed that women had greater metoprolol exposure 
than did the men and a greater reduction of the exercise 
heart rate (31). 
In our study, the 35-40% and 65-80% phases of the 
RR interval in males and the 35-45% and 70-80% phases 
of the RR interval in females showed the smallest slope, 
Table 3. Relationship of Parameters of Left Ventricular Function in Subjects without or with Propranolol and as 
Analyzed Using Unpaired Student t-test
Propranolol
P Value
No Medication  Medication 
Systolic blood pressure (mmHg)  123 ± 17   120 ± 14  0.0538
Diastolic blood pressure (mmHg)   80 ± 10   80 ± 11 0.7018
Real-EDV (mL/m
2) 69.4 ± 9.3 70.6 ± 8.9 0.501
Real-ESV (mL/m
2) 23.5 ± 5.7 25.6 ± 3.7 0.0155*
Real-EF (%) 66.5 ± 5.1 63.5 ± 4.6 0.0016*
Note.— Real-EDV = real-end diastolic volume of left ventricle, Real-ESV = real-end systolic volume of left ventricle, Real-EF = real-
ejection fraction 
*for significant values
Fig. 2. Mean volume-time curve obtained from data of twenty 
phases’ reconstruction. 
35-40% and 65-80% phases of R-R interval in males (dash line) and 
35-45% and 70-80% phases in females (solid line) showed smallest 
slope, which indicated least volumetric change.
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which indicates the least LV volumetric change. These 
are the most frequent reconstruction phases we used for 
the evaluation of the coronary arteries (32). One study 
claimed that 64-slice CT coronary angiography provided 
the best image quality in mid-diastole such as the 60% 
and 65% phases with using a Siemens 64-slice CT scanner 
(33). In another study using dual-source CT, the optimal 
reconstruction phase was at 75% of the R-R interval in 
subjects with low or intermediate heart rates. In patients 
with heart rates faster than 80 beats per minutes, the 
systolic reconstructions often yield superior image quality 
as compared to the diastolic reconstructions (34). The 
slightly different preference in phase selection could be 
related to the different definition of the % phase of the 
R-R interval of different CT scanners, such as the beginning 
of the acquisition window within the R-R interval for the 
Siemens scanner and the center of the acquisition window 
for the General Electric, Philips and Toshiba scanners. 
Left ventricular EF is one of the indices of cardiac 
function and it is usually evaluated by the safer but 
operator dependant echocardiography. It can be calculated 
from post-processing of the raw data from the CT coronary 
angiography by retrospective reconstruction of the systolic 
phase and diastolic phase images, which is nearly as good 
as MRI and better than two-dimensional echocardiography 
or ECG-gated single photon emission computed tomography 
(SPECT) (23-26). Underestimation of the left ventricular 
volume in our study is possible due to the exclusion of some 
volume below the mitral valve when we set the upper limit 
at the concave center of the mitral valve. Overestimation 
or underestimation of the LV volume has been reported 
because of the different criteria for selecting the 
endocardial boundary or the inclusion/exclusion of papillary 
muscle (6-15, 18, 20-24). Estimation of the real-EF from 
all twenty phases is more precise; however, this takes more 
than half an hour with some efforts. From our results, direct 
choices of the 40% RR interval as the systolic phase and 
the 0% RR interval as the diastolic phase are recommended 
because the real-ESV has no statistically significant 
difference compared to the 40% phase LV volume, and the 
EF calculated from the 0-40% phase volume has the least 
variation (2%) from the real-EF, and this is similar to the 
conclusion of Suzuki’s study (17). 
One study reported that propranolol administration in the 
normal subjects decreased the resting heart rate and the 
EF, it increased the EDV and ESV, but had no effect on the 
systolic and diastolic blood pressure, although the sample 
size was small (28). Some of the animal and patient studies 
have demonstrated that medicating with beta-blocker in 
subjects who have cardiac disease results in a significant 
reduction of the heart rate and ejection fraction, whereas 
the EDV and ESV are increased (27, 29). One animal study 
reported that the inhibitory effects of propranolol on the LV 
function were represented by the negative inotropic action 
on cardiac contractility, which was shown as an increase in 
the ESV and a marked reduction in the HR, but there was 
little dilating action on the EDV (30). Similarly, our results 
revealed that propranolol had no effect on the SBP and DBP, 
but it caused an increase of the ESV, which contributed 
to the decrease of the EF; the EDV was not statistically 
influenced by propranolol medication, but a slight increase 
was noted. 
Our study had some limitations. First, different subject 
groups were compared for the assessing the effect of beta-
blocker effect, although we used age- and gender-matched 
inclusion criteria to minimize the heterogeneity. Second, 
there may have been additional independent variables that 
affected the reduction of the heart rate such as variability 
of the vasovagal response while breath holding or individual 
differences of susceptibility to the beta-blocker.
In conclusion, the difference of heart rate is only 
significantly influenced by gender and the use of 
propranolol. In addition to the decreased heart rate, 
propranolol will also increase the end systolic volume of 
the left ventricle, which contributes to a decrease in the 
ejection fraction, while the systolic blood pressure, diastolic 
blood pressure and the end diastolic volume of the left 
ventricle are not statistically changed. 
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